Summit Securities Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | – | – | 493 |
|
|
2024
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 430 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | – | – | 639 |
|
|
2022
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 894 |
|
|
2015
Q1 | – | Sell |
-100
| Closed | -$10K | – | 336 |
|
|
2014
Q4 | $10K | Buy |
+100
| New | +$10K | ﹤0.01% | 380 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | -$3K | – | 307 |
|
|
2013
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 332 |
|